Clinical Trial

Measurement of Mass Change in Serum Albumin Compared to Serum Lactic Acid as Predictive Tool for Sepsis Prognosis in Non Surgical ICU Patients

Name: Measurement of Mass Change in Serum Albumin Compared to Serum Lactic Acid as Predictive Tool for Sepsis Prognosis in Non Surgical ICU Patients — clinical trial record (NCT07289906)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to assess the reliability of measurement of mass change in serum albumin compared to serum lactic acid as predictive tool for sepsis prognosis in nonsurgical ICU patients

Trial Details

NCT Number	NCT07289906
Lead Sponsor	Ain Shams University
Conditions	Prognosis Prediction of Sepsis in Icu Patients
Enrollment	40 participants
Start Date	2025-09-28
Primary Completion	2026-09-28 (estimated)
Study Completion	2026-09-28 (estimated)
Updated on ClinicalTrials.gov	2025-12-17